Use of thyroid hormones in hypothyroid and euthyroid patients: A survey of members of the Endocrine Society of Australia
Authors' conclusion
Australian endocrinologists mostly follow international guidelines when prescribing thyroid hormone therapy and many prescribe combination LT3 and LT4 therapy, particularly for patients who remain symptomatic on LT4 monotherapy. Prescribing practices are largely similar to other countries who have completed similar questionnaires.
Study context
- Population
- Members of the Endocrine Society of Australia (ESA); questionnaires with complete demographic data analysedquestionnaires analysed
- Participants
- 87 members
- Outcome
- Thyroid hormone prescribing practices
Methodological detailsonline questionnaire survey
- Online questionnaire survey
Main finding
As reported in the abstract
- Levothyroxine (LT4) used as first-line treatment for hypothyroidism
- all respondents
- Patients dispensed the LT4 brand they recommend
- 45%
- Liothyronine (LT3) (alone or in combination) prescribed in clinical practice
- 44%
- Would consider LT3 + LT4 in patients with normal TSH and ongoing hypothyroid symptoms
- 49%
- Would consider LT3 + LT4 for themselves if diagnosed with hypothyroidism
- 32%
- Would not prescribe thyroid hormone to euthyroid individuals
- 55%
- Would consider use in euthyroid female infertility with high thyroid antibodies
- 39%
- Would consider use in euthyroid patients with simple goitre growing over time
- 11%
Observational data: associations, not effects.
Original publication
Use of thyroid hormones in hypothyroid and euthyroid patients: A survey of members of the Endocrine Society of Australia. Clin Endocrinol (Oxf). Published 11 March 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →